Related Experiment Videos
[Serum apolipoproteins in uremic patients]
Zhonghua Nei Ke Za Zhi
|July 1, 1993
Summary
Uremic patients show abnormal apolipoprotein levels, indicating potential lipid metabolism disturbances and atherosclerosis risk. Apolipoproteins may predict cardiovascular complications better than standard lipids in uremia.
Area of Science:
- Biochemistry
- Clinical Medicine
- Cardiovascular Research
Context:
- Uremia is a complex condition associated with significant cardiovascular risks.
- Altered lipid metabolism is a known complication of chronic kidney disease.
- Apolipoprotein profiles offer insights into lipid transport and cardiovascular health.
Purpose:
- To investigate serum apolipoprotein and lipid profiles in Chinese patients with uremia.
- To compare these profiles with sex- and age-matched healthy controls.
- To determine the predictive value of apolipoproteins versus lipids for cardiovascular complications in uremia.
Summary:
- Chinese patients with uremia exhibited reduced Apolipoprotein AI (Apo AI) and Apo AI/Apo B100 ratio, alongside increased Apolipoprotein CII (Apo CII) and Apolipoprotein CIII (Apo CIII) levels.
- Despite normal total cholesterol (TC) and triglycerides (TG), patients showed decreased high-density lipoprotein cholesterol (HDL-C) and HDL2-C.
- These findings indicate widespread apolipoprotein abnormalities in uremia, potentially driving lipid metabolism disturbances and atherosclerosis development.
Impact:
- Apolipoprotein abnormalities in uremia may precede or occur independently of overt dyslipidemia.
- Apolipoproteins could serve as superior biomarkers for predicting cardiovascular complications in uremic patients compared to traditional lipid panels.
- This research highlights the importance of assessing apolipoprotein profiles for comprehensive cardiovascular risk management in uremia.